Cancer immune therapy using engineered ‛tail-flipping’ nanoliposomes targeting alternatively activated macrophages
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2041-1723
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Cancer immune therapy using engineered ‛tail-flipping’ nanoliposomes targeting alternatively activated macrophages ; volume:13 ; number:1 ; day:4 ; month:8 ; year:2022 ; pages:1-17 ; date:12.2022
Nature Communications ; 13, Heft 1 (4.8.2022), 1-17, 12.2022
- Urheber
-
Kuninty, Praneeth R.
Binnemars-Postma, Karin
Jarray, Ahmed
Pednekar, Kunal P.
Heinrich, Marcel A.
Pijffers, Helen J.
Hoopen, Hetty ten
Storm, Gert
Hoogevest, Peter van
Otter, Wouter K. den
Prakash, Jai
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41467-022-32091-9
- URN
-
urn:nbn:de:101:1-2022101921535135252372
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:29 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kuninty, Praneeth R.
- Binnemars-Postma, Karin
- Jarray, Ahmed
- Pednekar, Kunal P.
- Heinrich, Marcel A.
- Pijffers, Helen J.
- Hoopen, Hetty ten
- Storm, Gert
- Hoogevest, Peter van
- Otter, Wouter K. den
- Prakash, Jai
- SpringerLink (Online service)
Ähnliche Objekte (12)
Therapeutic Targeting of Hepatic Macrophages
Differential sensitivity of inflammatory macrophages and alternatively activated macrophages to ferroptosis
Analysis of translation in early activated macrophages
Targeting of activated macrophages through CD64 to elucidate their role in the pathogenesis of Multiple sclerosis
Engineered CD147-CAR macrophages for enhanced phagocytosis of cancers
Mmu-miR-125b overexpression suppresses NO production in activated macrophages by targeting eEF2K and CCNA2
Engineered Methyltransferase-Catalyzed Terminal Prenyl Group Tail Methylation of Linear Terpenoids
Targeting tauopathy with engineered tau-degrading intrabodies
Transcriptional and epigenetic regulation of differentially activated macrophages
Targeting immunotoxins to activated T-lymphocytes
Targeting tumor-associated macrophages for cancer treatment
Advances in Engineered Macrophages: A New Frontier in Cancer Immunotherapy
Therapeutic Targeting of Hepatic Macrophages
Differential sensitivity of inflammatory macrophages and alternatively activated macrophages to ferroptosis
Analysis of translation in early activated macrophages
Targeting of activated macrophages through CD64 to elucidate their role in the pathogenesis of Multiple sclerosis
Engineered CD147-CAR macrophages for enhanced phagocytosis of cancers
Mmu-miR-125b overexpression suppresses NO production in activated macrophages by targeting eEF2K and CCNA2
Engineered Methyltransferase-Catalyzed Terminal Prenyl Group Tail Methylation of Linear Terpenoids
Targeting tauopathy with engineered tau-degrading intrabodies
Transcriptional and epigenetic regulation of differentially activated macrophages
Targeting immunotoxins to activated T-lymphocytes
Targeting tumor-associated macrophages for cancer treatment
Advances in Engineered Macrophages: A New Frontier in Cancer Immunotherapy
Therapeutic Targeting of Hepatic Macrophages
Differential sensitivity of inflammatory macrophages and alternatively activated macrophages to ferroptosis
Analysis of translation in early activated macrophages
Targeting of activated macrophages through CD64 to elucidate their role in the pathogenesis of Multiple sclerosis
Engineered CD147-CAR macrophages for enhanced phagocytosis of cancers
Mmu-miR-125b overexpression suppresses NO production in activated macrophages by targeting eEF2K and CCNA2
Engineered Methyltransferase-Catalyzed Terminal Prenyl Group Tail Methylation of Linear Terpenoids
Targeting tauopathy with engineered tau-degrading intrabodies
Transcriptional and epigenetic regulation of differentially activated macrophages
Targeting immunotoxins to activated T-lymphocytes
Targeting tumor-associated macrophages for cancer treatment